These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8438916)

  • 1. Peripartum heart failure associated with prolonged tocolytic therapy.
    Lampert MB; Hibbard J; Weinert L; Briller J; Lindheimer M; Lang RM
    Am J Obstet Gynecol; 1993 Feb; 168(2):493-5. PubMed ID: 8438916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rebound hyperkalemia after cessation of intravenous tocolytic therapy with terbutaline in the treatment of preterm labor: anesthetic implications.
    Kuczkowski KM; Benumof JL
    J Clin Anesth; 2003 Aug; 15(5):357-8. PubMed ID: 14507561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The occurrence of adverse events in women receiving continuous subcutaneous terbutaline therapy.
    Elliott JP; Istwan NB; Rhea D; Stanziano G
    Am J Obstet Gynecol; 2004 Oct; 191(4):1277-82. PubMed ID: 15507953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pulmonary edema during terbutaline infusion against threatened premature labor].
    Rasmussen OB; Larsen B
    Ugeskr Laeger; 1993 Apr; 155(17):1303-4. PubMed ID: 8506581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dosing of subcutaneous terbutaline pump tocolytic therapy is critical.
    Lam F
    Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 1):1156-7. PubMed ID: 1415415
    [No Abstract]   [Full Text] [Related]  

  • 6. Incidence of adverse cardiopulmonary effects with low-dose continuous terbutaline infusion.
    Perry KG; Morrison JC; Rust OA; Sullivan CA; Martin RW; Naef RW
    Am J Obstet Gynecol; 1995 Oct; 173(4):1273-7. PubMed ID: 7485336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atrial fibrillation in pregnancy associated with oral terbutaline therapy.
    Lashgari S; Kueck AS; Oyelese Y
    Obstet Gynecol; 2003 Apr; 101(4):814. PubMed ID: 12681894
    [No Abstract]   [Full Text] [Related]  

  • 8. A prospective comparison of terbutaline and magnesium for tocolysis.
    Chau AC; Gabert HA; Miller JM
    Obstet Gynecol; 1992 Nov; 80(5):847-51. PubMed ID: 1407926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential diagnosis of postpartum pulmonary edema.
    Van Dyke JJ
    Chest; 1995 Nov; 108(5):1478-9. PubMed ID: 7587474
    [No Abstract]   [Full Text] [Related]  

  • 10. Atrial fibrillation in pregnancy associated with oral terbutaline.
    Carson MP; Fisher AJ; Scorza WE
    Obstet Gynecol; 2002 Nov; 100(5 Pt 2):1096-7. PubMed ID: 12423819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The oxytocin antagonist atosiban versus the beta-agonist terbutaline in the treatment of preterm labor. A randomized, double-blind, controlled study.
    European Atosiban Study Group
    Acta Obstet Gynecol Scand; 2001 May; 80(5):413-22. PubMed ID: 11328217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term magnesium sulfate tocolysis and maternal osteoporosis in a triplet pregnancy: a case report.
    Levav AL; Chan L; Wapner RJ
    Am J Perinatol; 1998 Jan; 15(1):43-6. PubMed ID: 9475687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. The Worldwide Atosiban versus Beta-agonists Study Group.
    Worldwide Atosiban versus Beta-agonists Study Group
    BJOG; 2001 Feb; 108(2):133-42. PubMed ID: 11236112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Terbutaline and methergine in look-alike packaging.
    Simpson KR
    MCN Am J Matern Child Nurs; 2004; 29(3):208. PubMed ID: 15123981
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term subcutaneous terbutaline tocolysis: report of possible neonatal toxicity.
    Thorkelsson T; Loughead JL
    J Perinatol; 1991 Sep; 11(3):235-8. PubMed ID: 1919821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tocolytics for preterm premature rupture of membranes.
    Mackeen AD; Seibel-Seamon J; Grimes-Dennis J; Baxter JK; Berghella V
    Cochrane Database Syst Rev; 2011 Oct; (10):CD007062. PubMed ID: 21975760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interval to spontaneous delivery following discontinuation of maintenance tocolysis.
    Jones JS; Morrison J; Istwan N; Rhea D; Collins A; Stanziano G
    J Matern Fetal Neonatal Med; 2006 Jun; 19(6):331-5. PubMed ID: 16801308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute paraparesis due to terbutaline sulfate.
    Herskowitz A; Herskowitz B
    South Med J; 2002 Feb; 95(2):275-6. PubMed ID: 11846262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripartum cardiomyopathy and acute heart failure associated with prolonged tocolytic therapy in pregnancy: A case report.
    Li PC; Chang HR; Kao SP
    Medicine (Baltimore); 2021 Aug; 100(34):e27080. PubMed ID: 34449509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A critical appraisal of the potential harmful effects of terbutaline sulfate use in pregnancy.
    Elliott JP; Morrison JC; Chauhan SP
    J Reprod Med; 2013; 58(3-4):123-31. PubMed ID: 23539880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.